Clinical Trials
1,426 trialsEvaluation for NCI Surgery Branch Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
OCTANE
University Health Network, Toronto
A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
Sun Yat-sen University
Medical and Psychosocial Issues in Adolescents and Young Adults With Colorectal Cancer
University of Southern California
OrigAMI-1
Janssen Research & Development, LLC
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
National Institutes of Health Clinical Center (CC)
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer
Roswell Park Cancer Institute
Resistance Exercise and Creatine in Colorectal Cancer
University of South Carolina
OrigAMI-2
Janssen Research & Development, LLC
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Perspective Therapeutics
OrigAMI-3
Janssen Research & Development, LLC
Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]
M.D. Anderson Cancer Center
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
Janssen Research & Development, LLC
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
GlaxoSmithKline
Natural History Study of Early Life Exposures in Agriculture (ELEA)
National Institutes of Health Clinical Center (CC)
Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial
Mayo Clinic
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
University of Arizona
Impact of SMS Messaging on Participation in Colorectal Cancer Screening.
Corporacion Parc Tauli
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Blueprint Medicines Corporation
Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
Novartis
PIFA
UMC Utrecht
PLCRC
Dutch Colorectal Cancer Group
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
Pfizer
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
xCures
PF-07284892 in Participants With Advanced Solid Tumors
Pfizer
MOUNTAINEER-03
Seagen Inc.
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory
Northwestern University
PREPCOLON
Hospital del Rio Hortega
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Context Therapeutics Inc.
panSOHO
Bayer
A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
Fred Hutchinson Cancer Center
A Clinical Study of Arfolitixorin in Patients With mCRC
Isofol Medical AB
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
ArriVent BioPharma, Inc.
BILMOD
Massachusetts General Hospital
FiREBOLT
Eli Lilly and Company
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Pfizer
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients
Stanford University
CoSMMO
University of Colorado, Denver
AI-Integrated Emotional Granularity Training for Resilience and Quality of Life in Colorectal Cancer Survivors
The Hong Kong Polytechnic University
AI-empowered Nudge to Improve Colonoscopy Uptake (AINC)
Fudan University
Impact of Fusobacterium Nucleatum on Response to Anti-EGFR Therapy in Metastatic Colorectal Cancer
Barretos Cancer Hospital
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Memorial Sloan Kettering Cancer Center
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study
National Cancer Institute (NCI)
da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures
Intuitive Surgical
CARABiNER
Lyell Immunopharma, Inc.
PROACC-1
Pfizer
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Revolution Medicines, Inc.